A 10- to 12-year follow-up study of delta ceramic-on-ceramic total hip arthroplasty.
Jung-Wee Park, Hong-Seok Kim, Ki-Choul Kim...
https://pubmed.ncbi.nlm.nih.gov/36595032/Actively Recruiting
Led by Seoul National University Bundang Hospital · Updated on 2026-09-18
210
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are evaluating how well a hip replacement using the collarless Actis femoral stem performs over five years in Asian patients. This study focuses on people aged 18 years or older who are scheduled for primary total hip arthroplasty due to conditions like osteoarthritis, developmental dysplasia, rheumatoid or non-rheumatoid inflammatory arthritis, post-traumatic arthritis, osteonecrosis of the femoral head, or displaced femoral neck fracture. The collarless Actis stem is designed to bond directly with the thigh bone without bone cement and has been mostly studied in Western populations with a collared version. All participants receive a primary cementless total hip arthroplasty using the collarless Actis femoral stem combined with a Pinnacle acetabular cup and a fourth-generation ceramic-on-ceramic bearing. The surgery is performed through a posterior approach with the patient lying on their side. After surgery, participants begin mobilization within one or two days, using a walking aid with partial weight bearing for six weeks. Follow-up visits occur at 6 weeks, 3 months, 12 months, and then annually up to 5 years, matching routine care visits. During follow-up, researchers assess hip function and implant status using routine X-rays, questionnaires on hip pain, daily activities, and overall health. They monitor for orthopedic complications such as dislocation, infection, bone fractures around the implant, or loosening of the implant. Patient-reported outcomes include scores for hip disability, activity level, and joint awareness. Data collection continues for five years, and safety and data quality are regularly checked throughout the study.
CONDITIONS
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem
J
Jung-Wee Park, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Seoul National University Bundang Hospital
Lead Sponsor
Johnson & Johnson Medical Korea Ltd
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (preoperative assessment)
Duration - 6 weeks
Participants undergo primary cementless total hip arthroplasty using the collarless Actis stem and begin mobilization with partial weight bearing using a walking aid for six weeks.
Hospital stay and early postoperative assessments
Duration - Up to 5 years
Participants return for routine follow-up visits at 6 weeks, 3 months, 12 months, and then annually up to 5 years to monitor implant status, hip function, and any complications.
Visits at 6 weeks, 3 months, 12 months, then yearly
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jung-Wee Park, Hong-Seok Kim, Ki-Choul Kim...
https://pubmed.ncbi.nlm.nih.gov/36595032/Seoul National University Bundang Hospital
Lead Sponsor
Johnson & Johnson Medical Korea Ltd
Collaborating Sponsor